Volume 18, Number 2—February 2012
CME ACTIVITY - Research
Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010
|Calculation||A. Patients with campylobacteriosis
||B. Patients hospitalized for campylobacteriosis
||C. Patients hospitalized for GBS
||D. Patients hospitalized for GBS and campylobacteriosis‡
|Age, y||Age, y||p value for age compared with A§||Age, y||p value for age compared with B§||Age, y||p value for age compared with C§|
*GBS, Guillain-Barré syndrome.
‡Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
§Means compared with Student t-test medians compared with median 2-sample test.
- Page created: January 26, 2012
- Page last updated: January 26, 2012
- Page last reviewed: January 26, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)